Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

GSK Biologicals Manufacturing Plant

Project Type

Vaccine production plant expansion

Location

Dresden, Germany

Owner

GSK Biologicals

Investment

€125m

Construction Started

August 2005

Completed

Commissioning by October 2007; fully operational by February 2008

Major Vaccines Produced

Fluarix, Prepandrix

Capacity

70 million doses

Gross Floor Area

29,990m²

Cleanroom Area

6,200m²

General Contractor

LSMW GmbH

Architect

HWP Planungsgesellschaft mbH

Other Partners

Linde (plant design)

Plant Automation

Siemens
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM
Close
Close
Close

Go Top